CVS Health Says GLP-1s Would Pay for Themselves Near $350 a Month. At Today's Prices, They Do Not Yet.

CVS Health looked at three years of Aetna claims. GLP-1 users went to the hospital less and had lower medical bills, but the medicine cost more than it saved. Here is what the numbers say and why it matters for coverage.

Order Meals — View This Week's Menu

By Lew Kizer — 2026-11-21 — Health & Nutrition

The short answer

A CVS Health white paper released Nov. 15, 2026, used Aetna claims to compare GLP-1 users with similar non-users for up to three years. GLP-1 users had 34% to 42% lower hospitalization rates and, by year 3, about $9,400 lower medical spending per member. But net pharmacy spending was about $13,300 higher, so total cost of care was about $3,900 higher. CVS estimates a net price of about $350 a month would balance the two. It is an observational company analysis, not a peer-reviewed trial.

Key facts

  • CVS Health released the white paper "GLP-1s: Good Drugs, High Prices" on Nov. 15, 2026. Authors: Raj K. Patel, MD; Kelly Jean Craig, PhD; and Amy Compton-Phillips, MD, of CVS Health Medical Affairs.
  • Data: anonymized Aetna claims for commercial fully insured members who started a GLP-1, index years 2023 through 2025, with up to three years of follow-up. Each user was matched 1:1 with a similar non-user. CVS did not publish the number of members.
  • Hospitalization rates were 34% to 42% lower across the three follow-up years. Emergency visits were 10% to 12% lower in years 1 and 2. Odds of a major heart event were 14% lower in the earlier-year analyses.
  • Year 3, all users: medical spending about $9,400 lower, net pharmacy spending about $13,300 higher, total cost of care about $3,900 higher per member.
  • Year 3, members who kept their prescriptions filled at least 80% of days: medical spending about $13,000 lower, pharmacy about $20,300 higher, total about $7,300 higher.
  • CVS models break-even at a net price of about $350 a month over three years, averaged across the study group. It says this is not a price recommendation and does not apply to every patient.
  • The paper says the study shows associations, not cause and effect.

KINGSPORT, Tenn., Nov. 21, 2026 — Do GLP-1 medicines save enough on hospital bills to pay for themselves? CVS Health's answer, in a white paper released Nov. 15, is "at current prices, not yet." Using three years of Aetna insurance claims, its researchers found people who started a GLP-1 went to the hospital less and had lower medical bills than similar people who did not. The medicine itself still cost more than those savings. CVS estimates the math would even out at a net price of about $350 a month. The paper has drawn wide coverage this week from benefits and health-policy outlets as employers set next year's plans.

This article reports medical and health-policy news and is not medical advice. SmashMeals is a food company, not a medical provider, and is not affiliated with the companies or researchers named here. Talk with your doctor before you start, stop or change any medicine.

What CVS studied

The researchers used anonymized claims from Aetna's commercial fully insured members, the kind of coverage many people get through work. They looked at people who started a GLP-1 from 2023 through 2025 and matched each one with a similar person who did not, based on age, health conditions, past care and past spending. Each year of follow-up was matched and analyzed on its own, so the paper says the results should not be read as one group tracked over time.

The full paper does not list how many members were included. It does say fewer people had three full years of data, so the year-3 group was smaller.

What they found

Per member, year 3All GLP-1 usersFilled at least 80% of days
Medical spendingabout $9,400 lowerabout $13,000 lower
Net pharmacy spendingabout $13,300 higherabout $20,300 higher
Total cost of careabout $3,900 higherabout $7,300 higher

Compared with matched non-users, all GLP-1 users had 34% to 42% lower hospitalization rates across the three years and 10% to 12% fewer emergency visits in years 1 and 2. In the earlier-year analyses they had 14% lower odds of a major heart event. People who kept their prescriptions filled had larger differences, but the paper warns those people may differ in other ways, so the gap should not be credited to sticking with the medicine alone.

A note on the numbers: some coverage describes the 34% to 42% hospital figure as a year-3 result. The white paper says it applies "across the three years" of follow-up, and that is the wording used here.

Where the $350 comes from

CVS modeled the net price at which pharmacy spending and medical savings would balance over three years. Its answer, about $350 a month, is an average across the study group. The paper says the figure "should not be considered universally applicable estimates or price recommendations," and that the real break-even depends on a person's health risk, how long they stay on treatment and how consistently they take it.

"GLP-1s are remarkably effective medicines, and the health benefits are real," said Dr. Amy Compton-Phillips of CVS Health. "The challenge is making those benefits affordable at scale." The paper asks drug makers to offer health plans and employers net prices at least as low as the cash prices they offer patients directly for the same product and dose.

CVS also lists limits. The study shows associations, not cause and effect. Matching cannot account for every difference between groups, and a filled prescription does not prove the medicine was taken.

What it means at the kitchen table

For many families, the bigger question is not a health plan's three-year math but whether coverage will be there next year. Our earlier story on Lilly's quarter and employer coverage covers that side. Whatever happens with coverage, appetite on a GLP-1 is smaller and protein has to fit into less food. Our GLP-1 meal planning page and the illustrative 7-day GLP-1 meal plan are places to start, and GLP-1 maintenance meals covers the stretch after you reach a goal or change medicines. None of it replaces advice from your prescriber or a registered dietitian.

“When you're on a GLP-1 medication, what you eat matters more, not less. You need high-protein, portion-controlled, nutrient-dense food — and you need to know it's safe. That's exactly what we do.” — Lew Kizer, Founder, SmashMeals

Thanksgiving with a smaller appetite? Our gluten-free Thanksgiving menu sells items one at a time. Thanksgiving deadlines: Thanksgiving ordering is closed.. Pick up locally or order for shipping; checkout confirms timing. See this week's meals.

Commentary, not medical advice

The SmashMeals perspective

Coverage fights are real for families here in the Tri-Cities, and a lot of people are paying cash or worrying they will lose their plan. Whatever the price of the medicine, the grocery side of the budget still counts. We sell meals one at a time with no subscription, portioned and protein-forward, so people can eat well on a GLP-1 without paying for food they will not finish.

Frequently asked questions

Does this study say GLP-1s are worth it?

It says the health benefits look real in claims data, with fewer hospital stays and emergency visits. It also says that at current prices the drug cost was more than the medical savings over three years. CVS says break-even should not be the only way to judge a medicine's value.

What is a net price?

It is what a health plan actually pays for a drug after rebates and discounts, which is usually below the list price. CVS did not say what net price it pays today.

Is $350 a month the price I would pay?

No. It is CVS's estimate of the average net price at which a health plan's drug spending and medical savings would even out over three years. It is not a cash price or a copay.

Was this a clinical trial?

No. It was a look back at insurance claims with users matched to similar non-users. The authors say it shows associations and cannot prove cause, and that claims show a prescription was filled, not that it was taken.

Why does this matter if I am on a GLP-1?

Employers and health plans use studies like this when they decide whether to cover GLP-1s for weight loss. If your coverage changes, talk with your prescriber and your plan about options before you stop or switch.

Sources and credits

Follow the original sources for context and verification. A reference is not an endorsement of SmashMeals.

More SmashMeals news

Order Meals — View This Week's Menu